ORF7a, Mitochondrial Reprogramming, and Testable Intervention Concepts

Abstract

A recent cell-model study reports that the SARS-CoV-2 accessory protein ORF7a increases PDK4, inhibits pyruvate dehydrogenase (PDH), impairs mitochondrial Complex I and respiratory-supercomplex organization, increases oxidative stress, and redirects metabolism away from efficient mitochondrial glucose oxidation. This paper separates those observations from two further steps: first, a reasoned hypothesis that a similar stress program in monocytes or dendritic cells could disturb antigen-presentation biology; and second, speculative intervention concepts involving an ORF7a-dependent host partner, a decoy binder, an allosteric trap, or directed protein degradation. A terahertz (THz) concept is retained only as a distant measurement and biophysics question. There is currently no evidence that THz exposure can selectively neutralize ORF7a in tissue, and no clinical use is proposed.